MiZ Company

MiZ Company is a Japan-based healthcare technology and biotech-oriented company focused on the medical use of molecular hydrogen. The company develops hydrogen administration technologies, including gas inhalation devices, hydrogen-enriched liquid preparation systems, and super-saturated hydrogen water systems, and positions these as enabling platforms for clinical application. MiZ has built a substantial patent estate around hydrogen delivery and has published collaborative research with institutions including Keio University, Osaka Metropolitan University, and the University of California, Berkeley. Its work spans multiple disease areas linked to oxidative stress and chronic inflammation, with recent communications highlighting Parkinson's disease, ALS, stroke-related sequelae, colitis, and supportive-care applications. Based on publicly available information, MiZ appears to operate primarily as a research, platform, and device-enabling company rather than a conventional therapeutic developer with a clearly disclosed drug pipeline.